Badar, Talha http://orcid.org/0000-0003-1548-918X
Szabo, Aniko http://orcid.org/0000-0002-8129-0614
Litzow, Mark http://orcid.org/0000-0002-9816-6302
Burkart, Madelyn
Yurkiewicz, Ilana
Dinner, Shira
Hefazi, Mehrdad
Shallis, Rory M.
Podoltsev, Nikolai http://orcid.org/0000-0002-3657-778X
Patel, Anand A.
Curran, Emily
Wadleigh, Martha
Balasubramanian, Suresh
Yang, Jay
Arslan, Shukaib
Aldoss, Ibrahim
Mattison, Ryan
Cenin, Danielle
Siebenaller, Caitlin
Advani, Anjali
Liedtke, Michaela
Atallah, Ehab
Article History
Received: 31 August 2020
Revised: 24 February 2021
Accepted: 24 March 2021
First Online: 6 April 2021
Compliance with ethical standards
:
: TB received Mayo Clinic Cancer Center support grant (P30 CA015083) and in advisory board for Pfizer, NAP consulted for and received honoraria from Alexion, Pfizer, Agios Pharmaceuticals, Blueprint Medicines, Incyte, Novartis, Celgene, Bristol-Myers Squib, CTI BioPharma and PharmaEssentia. NAP received research funding (all to the institution) from Boehringer Ingelheim, Astellas Pharma, Daiichi Sankyo, Sunesis Pharmaceuticals, Jazz Pharmaceuticals, Pfizer, Astex Pharmaceuticals, CTI biopharma, Celgene, Genentech, AI Therapeutics, Samus Therapeutics, Arog Pharmaceuticals, Kartos Therapeutics. None of these relationships were related to the development of this paper.